Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Robert Kyle

Robert Kyle

MD
Mayo Clinic, Rochester, MI

Robert Kyle, MD, Mayo Clinic, Rochester, MI, is responsible for a great deal of the medical information we now have on myeloma, having published more than 1,850 scientific papers and abstracts on the disease. In 2008, Dr Kyle was awarded the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the society’s highest honor.

Dr Kyle went to Northwestern University Medical School in Chicago, IL, graduating with distinction in June 1952, he then did a rotating internship at Evanston Hospital, a major teaching hospital affiliated with Northwestern University Medical School.

 

PROMISE: why early detection of MGUS is vital to reducing MM incidence 13:16
PROMISE: why early detection of MGUS is vital to reducing MM incidence
Irene Ghobrial et al. • 14 Sep 2019
MGUS, smoldering myeloma & the need to monitor patients 2:11
MGUS, smoldering myeloma & the need to monitor patients
Robert Kyle • 19 Apr 2018
Clinical significance of smoldering myeloma 1:16
Clinical significance of smoldering myeloma
Robert Kyle • 19 Apr 2018
150 years of multiple myeloma therapy 4:57
150 years of multiple myeloma therapy
Robert Kyle • 19 Apr 2018
Promising new therapies for MM treatment 1:08
Promising new therapies for MM treatment
Robert Kyle • 19 Apr 2018
Curing multiple myeloma: have we done it? 1:04
Curing multiple myeloma: have we done it?
Robert Kyle • 19 Apr 2018
Myeloma progression: where does it begin? 1:23
Myeloma progression: where does it begin?
Robert Kyle • 19 Apr 2018
The content of VJHemOnc is intended for healthcare professionals